MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 5, 2012, Pages 407-414

  Fan, Lei ^a   Wu, Qiang ^a   Xing, Xiaojuan ^b   Wei, Yulong ^a   Shao, Zengwu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Southeast Forensic Science Service   (China)

Author keywords

Invasion; Metastasis; MiR 145; Osteosarcoma; Vascular endothelial growth factor

Indexed keywords

MICRORNA; MIRN145 MICRORNA, HUMAN; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ARTICLE; BIOSYNTHESIS; CANCER INVASION; CELL ADHESION; DOWN REGULATION; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OSTEOSARCOMA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

3' UNTRANSLATED REGIONS; CELL ADHESION; DOWN-REGULATION; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860445335     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms019     Document Type: Article

References (32)

1. Hartford CM, Wodowski KS, Rao BN, Khoury JD, Neel MD and Daw NC. Osteosarcoma among children aged 5 years or younger: the St. Jude Children's Research Hospital experience. J Pediatr Hematol Oncol 2006, 28: 43-47. (Pubitemid 43361619)
2. Ottaviani G and Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009, 152: 3-13.
3. Marina N, Gebhardt M, Teot L and Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 2004, 9: 422-441. (Pubitemid 39014554)
4. Zeng Y. Principles of micro-RNA production and maturation. Oncogene 2006, 25: 6156-6162. (Pubitemid 44527845)
5. Volk N and Shomron N. Versatility of microRNA biogenesis. PLoS One 2011, 6: e19391.
6. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281-297.
7. Zamore PD and Haley B. Ribo-gnome: the big world of small RNAs. Science 2005, 309: 1519-1524. (Pubitemid 41266468)
8. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A and Bartel DP. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 2010, 38: 789-802.
9. Lai EC. MicroRNAs: runts of the genome assert themselves. Curr Biol 2003, 13: 925-936.
10. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6: 259-269.
11. Hammond SM. MicroRNAs as tumor suppressors. Nat Genet 2007, 39: 582-583. (Pubitemid 46676097)
12. Brennecke J, Stark A, Russell RB and Cohen SM. Principles of microRNA-target recognition. PLoS Biol 2005, 3: e85.
13. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y. Decreased expression of microRNA-143 and-145 in human gastric cancers. Oncology 2009, 77: 12-21.
14. Chen X, Gong J, Zeng H, Chen N, Huang R, Huang Y and Nie L, et al. MicroRNA-145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res 2010, 70: 2728-2738.
15. Akao Y, Nakagawa Y and Naoe T. MicroRNAs-143 and-145 are possible common onco-microRNAs in human cancers. Oncol Rep 2006, 16: 845-850.
16. Akao Y, Nakagawa Y and Naoe T. MicroRNA-145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. Oncol Rep 2006, 16: 845-850.
17. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S and Elble R, et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009, 106: 3207-3212.
18. La Rocca G, Shi B, Audia A, Ferrari-Amorotti G, Mellert HS, Calabretta B and McMahon SB, et al. Regulation of miR-145 by growth arrest and differentiation. Exp Cell Res 2011, 317: 488-495.
19. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDC(T) method. Methods 2001, 25: 402-408. (Pubitemid 34164012)
20. Arnaoutova I, George J, Kleinman HK and Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 2009, 12: 267-274.
21. McArthur K, Feng B, Wu Y, Chen S and Chakrabarti S. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 2011, 60: 1314-1323.
22. Sachdeva M and Mo YY. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 2010, 70: 378-387.
23. Mohanraj D, Olson T and Ramakrishnan S. Expression of biologically active human vascular endothelial growth factor in yeast. Growth Factors 1995, 12: 17-27.
24. Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, Venzon D and Venitz J, et al. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther 2009, 8: 2496-2508.
25. Mei J, Gao Y, Zhang L, Cai X, Qian Z, Huang H and Huang W. VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro. Exp Oncol 2008, 30: 29-34. (Pubitemid 351518101)
26. Jung ST, Moon ES, Seo HY, Kim JS, Kim GJ and Kim YK. Expression and significance of TGF-beta isoform and VEGF in osteosarcoma. Orthopedics 2005, 28: 755-760.
27. Rennel E, Waine E, Guan H, Schü ler Y, Leenders W, Woolard J and Sugiono M, et al. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. Br J Cancer 2008, 98: 1250-1257. (Pubitemid 351481687)
28. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A and Lilenbaum R, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006, 355: 2542-2550. (Pubitemid 44917502)
29. Liu B, Peng XC, Zheng XL, Wang J and Qin YW. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 2009, 66: 169-175.
30. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D and Ji Y, et al. MiRNA-Directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 2006, 1: e116.
31. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q and Deitch EA, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009, 105: 158-166.
32. Riggi N, Suvà ML, De Vito C, Provero P, Stehle JC, Baumer K and Cironi L, et al. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev 2010, 24: 916-932.